Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug and one day after the Food and Drug ...
Hims & Hers Health stock fell Tuesday, the day after the telehealth company posted mixed quarterly results and issued a weak outlook for the current quarter. Shares tumbled 8.3% to $14.22, extending ...
Hims & Hers Health (NYSE: HIMS) delivered another quarter of strong revenue growth. But that came with shrinking margins, rising costs, and a surprise net loss. Will AI create the world's first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results